INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $42,597,932 | +21.5% | 1,044,579 | +11.1% | 0.05% | +15.9% |
Q1 2023 | $35,052,286 | +128376.7% | 940,496 | +20.3% | 0.04% | +12.8% |
Q4 2022 | $27,283 | -99.9% | 781,978 | +2.1% | 0.04% | -39.1% |
Q3 2022 | $42,874,000 | +30.3% | 766,162 | +20.5% | 0.06% | +39.1% |
Q2 2022 | $32,912,000 | +23.6% | 635,850 | +73.5% | 0.05% | +53.3% |
Q1 2022 | $26,636,000 | -46.6% | 366,533 | -13.1% | 0.03% | -40.0% |
Q4 2021 | $49,893,000 | +45.7% | 421,964 | +65.3% | 0.05% | +31.6% |
Q3 2021 | $34,238,000 | – | 255,224 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |